3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
32
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Neoplasm Metastasis
3
Carcinoma, Ovarian Epithelial
3
Pancreatic Neoplasms
2
Lung Neoplasms
2
Kidney Neoplasms
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms, Male
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Solid Malignancies
1
Sarcoma
1
Recurrent Uterine Corpus Sarcoma
1
Recurrence
1
Pain
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Adenocarcinoma
1
Interventions
Sunitinib
2
Paclitaxel
2
valrubicin
1
temsirolimus
1
sipuleucel-T
1
luprolide acetate gel depot
1
ferumoxtran-10
1
abiraterone
1
abemaciclib
1
Suspensions
1
Surveys and Questionnaires
1
Standard of Care
1
Radiotherapy
1
Prednisone
1
Prednisolone
1
Powders
1
Pemetrexed
1
Neoadjuvant Therapy
1
National Cancer Institute (U.S.)
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Leuprolide
1
Fatty Acids, Omega-3
1
Educational Status
1
Docetaxel
1
Bevacizumab
1
Atorvastatin
1
Administration, Intravesical
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urogenital Neoplasms
×
ixabepilone
×
Clear all
No trials found.